NASDAQ · Key Statistics

CASI Pharmaceuticals, Inc. (CASI) Key Statistics

$0.15 NASDAQ: CASI Market Cap $2.33M

Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for CASI Pharmaceuticals, Inc. (CASI), each with what it measures. Figures are trailing twelve months or the most recent reported period.

Valuation

Metric	Value
P/E ratioShare price divided by earnings per share.	-0.07
P/B ratioShare price divided by book value per share.	-0.08
P/S ratioMarket value divided by annual revenue.	0.17
PEG ratioP/E divided by the earnings growth rate.	0.00
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.	-0.54
EV / RevenueEnterprise value against annual revenue.	1.22
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.	-1428.57%
Free cash flow yieldFree cash flow as a percentage of market value.	0.00%
Price / free cash flowMarket value divided by free cash flow.	0.00

Profitability

Metric	Value
Gross marginRevenue left after the direct cost of goods sold.	47.32%
Operating marginRevenue left after operating costs.	-238.55%
Net marginRevenue left after every cost, including tax and interest.	-259.51%
Return on equityProfit as a percentage of shareholders’ equity.	184.34%
Return on assetsProfit as a percentage of total assets.	-143.11%
Return on capital employedOperating profit against the capital the business uses.	215.13%

Financial health

Metric	Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.	0.30
Quick ratioThe same, excluding inventory.	0.24
Cash ratioCash alone against current liabilities.	0.36
Debt to equityTotal borrowings against shareholders’ equity.	-0.66
Debt to assetsTotal borrowings against total assets.	0.41
Interest coverageHow many times operating profit covers the interest bill.	-50.60

Per share and size

Metric	Value
Earnings per shareProfit attributable to each share.	$-2.56
Book value per shareShareholders’ equity divided by shares outstanding.	$-1.78
Shares outstandingShares currently issued.	0
Market capitalisationShare price times shares outstanding.	$2.33M
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.	$11.33M

Dividend

Metric	Value
Dividend yieldAnnual dividend as a percentage of the share price.	0.00%
Payout ratioShare of profit paid out as dividends.	0.00%

CASI Pharmaceuticals, Inc. (CASI) statistics — frequently asked questions

What is CASI Pharmaceuticals, Inc.'s P/E ratio?

CASI Pharmaceuticals, Inc. (CASI) trades on a price-to-earnings ratio of -0.07. A negative P/E means the company reported a loss, so the ratio is not a meaningful valuation measure.

What is CASI Pharmaceuticals, Inc.'s return on equity?

CASI Pharmaceuticals, Inc. (CASI) reports a return on equity of 184.34%, meaning it generated that much profit for every dollar of shareholders' equity.

How much debt does CASI Pharmaceuticals, Inc. carry?

CASI Pharmaceuticals, Inc. (CASI) has a debt-to-equity ratio of -0.66, which compares total borrowings with shareholders' equity.

What is CASI Pharmaceuticals, Inc.'s profit margin?

CASI Pharmaceuticals, Inc. (CASI) keeps -259.51% of revenue as net profit after every cost, including tax and interest.

Related stock screens

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks High ROE Stocks Low P/E Stocks High Net Margin Stocks Dividend Stocks Low Debt Stocks Nasdaq High ROE Stocks All stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.